JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, S. M.
Right arrow Articles by Gerber, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, S. M.
Right arrow Articles by Gerber, N.

The seminal excretion, plasma elimination, tissue distribution and metabolism of naltrexone in the rabbit

SM Taylor, RM Rodgers, RK Lynn and N Gerber

The pharmacokinetics, tissue distribution and metabolism of naltrexone were studied in male New Zealand White rabbits. After an i.v. bolus, the plasma half-life of naltrexone between 30 min and 3 hr was 55 +/- 5 min and 53 +/- 3 min for 1 and 5 mg/kg doses of naltrexone . HCl, respectively. The drug concentration in the semen reached a maximum value between 15 and 30 min after the injection. At 120 min, the semen/plasma drug concentration ratio was 14 and 11 for the 1 and 5 mg/kg doses, respectively. Three minutes after injection, 95% of the drug had left the plasma. After 5 min, the conjugate levels exceeded the free drug levels in the plasma suggesting rapid glucuronidation of the drug. The concentrations of naltrexone and 6-beta-naltrexol were measured in different tissues 90 min after injection. Most of the tissues had drug concentrations which exceeded the concurrent plasma concentration. The highest concentrations were observed in the submaxillary gland. Relatively high amounts of 6-beta-naltrexol were found in the brain, fat, spleen, heart, testis, kidney and urine. The principle urinary metabolite was the glucuronide of naltrexone. Minor metabolites identified in urine treated with Glusulase were 6-beta- naltrexol and N-dealkylated naltrexone.

Volume 213, Issue 2, pp. 289-299, 05/01/1980
Copyright © 1980 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics.